Generex announces agreement to acquire equity interest in Alfa Rhythm Ltd.
Generex announced it has entered into a non-binding Letter of Intent with Alfa Rhythm Ltd., a private Israeli company that has developed a proprietary trans-cranial electro-biometric stimulator for treatment of symptoms of ADHD, depression, anxiety, and sleep disorders. October 06, 2015